AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 25 September 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00676-06v1
50/12/4053    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haenni, M.
Right arrow Articles by Moreillon, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haenni, M.
Right arrow Articles by Moreillon, P.
Antimicrob. Agents Chemother. doi:10.1128/AAC.00676-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Mutations in Penicillin-Binding Proteins (PBP) Genes and in non-PBP Genes During Selection of Penicillin-resistant Streptococcus gordonii

Marisa Haenni and Philippe Moreillon*

Department of Fundamental Microbiology, University of Lausanne, Switzerland

* To whom correspondence should be addressed. Email: philippe.moreillon{at}unil.ch.


   Abstract

Penicillin-resistance in Streptococcus spp. involves multiple mutations in both penicillin-binding proteins (PBPs) and non-PBP genes. Here we studied the development of penicillin-resistance in the oral commensal S. gordonii. Cyclic exposure of bacteria to 2-folds increasing penicillin concentrations selected for a progressive 250-500-fold MIC increase (from 0.008 to 2-4 µg/ml). The major MIC increase (≥ 35-fold) was related to non-PBP mutations, whereas PBP mutations accounted only for a 4 to 8-fold additional increase. PBP mutations occurred in the class B PBP 2X and 2B, which carry a transpeptidase domain, but not in class A PBP 1A, 1B or 2A, which carry an additional transglycosylase domain. Therefore, we tested whether inactivation of class A PBPs affected resistance development in spite of the absence of mutations. Deletion of PBP 1A or 2A profoundly slowed down resistance development, but only moderately affected resistance in already highly-resistant mutants (MIC = 2-4 µg/ml). Thus, class A PBPs might facilitate early development of resistance by stabilizing penicillin-altered peptidoglycan via transglycosylation, whereas they might be less indispensable in highly-resistant mutants which have re-established a penicillin-insensitive cell-wall building machinery. The contribution of PBP and non-PBP mutations alone could be individualized in DNA transformation. Both PBP and non-PBP mutations conferred some level of intrinsic resistance, but combining them together synergized to ensure high-level resistance (≥ 2 µg/ml). The results underline the complexity of penicillin-resistance development and suggest that inhibition of transglycosylase might be an as yet underestimated way to interfere with early resistance development.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.